Literature DB >> 18063506

Suspected malignant hyperthermia during sevoflurane anesthesia.

Shu-Chia Hsu1, Wei-Tai Huang, Huei-Ming Yeh, Allen Yi-Jer Hsieh.   

Abstract

Malignant hyperthermia is a rare anesthetic-related disorder. We present a case with unusual presentation. A boy aged 3 years and 9 months who was scheduled for Hotz's operation presented normally before the operation. Anesthesia was induced by atropine, thiopental and sevoflurane. Trachea intubation was facilitated by succinylcholine. Jaw stiffness was first noted although trachea was intubated without difficulty. The following tachycardia, hypercapnia and hyperthermia led to the diagnosis of malignant hyperthermia. Symptoms were relieved dramatically after the discontinuation of sevoflurane. Molecular genetic testing identified a novel ryanodine receptor (RYR1) mutation in exon 39, which confirmed malignant hyperthermia susceptibility in this patient.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18063506     DOI: 10.1016/S1726-4901(08)70050-9

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  2 in total

1.  Malignant Hyperthermia and Idiopathic HyperCKemia.

Authors:  Pashtoon Murtaza Kasi
Journal:  Case Rep Med       Date:  2011-11-23

2.  Delayed onset malignant hyperthermia after sevoflurane.

Authors:  K Sanem Cakar Turhan; Volkan Baytaş; Yeşim Batislam; Oya Ozatamer
Journal:  Case Rep Anesthesiol       Date:  2013-05-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.